[ad_1]
Pfzier’s new drug, Paxlovid, for Covid showed effectiveness against the Omicron variant in laboratory tests.
The company on Tuesday unveiled data showing that the Food and Drug Administration (FDA)-authorized pill to fight Covid, Paxlovid, was successful in three laboratory tests.
Nirmatrelvir, the active ingredient of the drug, showed that the effectiveness is neutralizing the virus in the tests done.
The Omicron variant has shown the ability to bypass Covid vaccines and treatments since it first appeared last year.
Pharmaceutical companies have worked to modify vaccines and treatments to be effective against the new strain of covid.
“We have created PAXLOVID specifically to maintain its effectiveness across coronaviruses as well as current variants,” Dr Michael Dolsten, of Pfizer, said in a statement.
He added that the antiviral pill showed the ability to reduce the risk of hospitalization or death from the virus by 90 percent if taken early.
top channel
[ad_2]
Source link
